Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients

被引：0
|
作者：
Numan, L. [1 ]
Aarts, E. [2 ]
Ramjankhan, F. [3 ]
Van der Meer, M. G. [1 ]
Oerlemans, M. [4 ]
De Jonge, N. [1 ]
Oppelaar, A. [3 ]
Kemperman, H. [5 ]
Asselbergs, F. [4 ]
Van Laake, L. W. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands
[2] Univ Utrecht, Methodol Stat, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Cardiothorac Surg, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands
[5] Univ Med Ctr Utrecht, Cent Diagnost Lab, Utrecht, Netherlands
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2023年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
834
引用
收藏
页码：S364 / S365
页数：2
相关论文
共 50 条
  • [41] THE PROGNOSTIC ROLE OF SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AMONG OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
    Agha, Ali
    Hussain, Aliza
    Shah, Amil
    Hoogeveen, Ron
    Sun, Carol
    Virani, Salim
    Nambi, Vijay
    Yu, Bing
    Selvin, Elizabeth
    Matsushita, Kunihiro
    Buckley, Leo
    Chen, Lin
    Dorbala, Pranav
    Ballantyne, Christie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1658 - 1658
  • [42] Soluble Suppression of Tumorigenicity-2 as a Candidate Prognostic Marker for Stroke A Systematic Review
    Ahmadzadeh, Koohyar
    Dizaji, Shayan Roshdi
    Balabandian, Mohammad
    Ramawad, Hamzah Adel
    Yousefifard, Mahmoud
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (06) : 585 - 595
  • [43] sST2 Protein Serum Levels in Patients with Chronic Heart Failure
    Tokmachev, R. E.
    Kravchenko, A. Ya
    Budnevsky, A., V
    Ovsyannikov, E. S.
    Chernik, T. A.
    Tokmachev, E., V
    Shkatova, Ya S.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2020, 10 (04) : 342 - 346
  • [44] Combination of sST2/LVMI Ratio and Modified MELD Scores Predicts Mortality in End-Stage Heart Failure
    Szczurek-Wasilewicz, Wioletta
    Jurkiewicz, Michal
    Skrzypek, Michal
    Romuk, Ewa
    Jozwiak, Jacek
    Gasior, Mariusz
    Szygula-Jurkiewicz, Bozena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [45] The Role of Suppression of Tumorigenicity-2 with Left Ventricular Global Strain and Aerobic Capacity in Systolic Heart Failure
    Rampengan, Starry Homenta
    Lampus, Nancy
    Gunadi, Johan
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2018, 12 (04) : 125 - 132
  • [46] A biomarker for bacteremia in pregnant women with acute pyelonephritis: soluble suppressor of tumorigenicity 2 or sST2
    Chatterton, Carolyn
    Romero, Roberto
    Jung, Eunjung
    Gallo, Dahiana M.
    Suksai, Manaphat
    Diaz-Primera, Ramiro.
    Erez, Offer
    Chaemsaithong, Piya
    Tarca, Adi L.
    Gotsch, Francesca
    Bosco, Mariachiara
    Chaiworapongsa, Tinnakorn
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2023, 36 (01):
  • [47] Prognostic value of sst2 in long-term mortality in acute heart failure
    Matyar, Selcuk
    Akpinar, Ayca Acikalin
    Disel, Nezihat Rana
    Avci, Akkan
    Caglayan, Caglar Emre
    Yildirim, Abdullah
    Akpinar, Onur
    ACTA CARDIOLOGICA, 2024, 79 (08) : 924 - 934
  • [48] Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis
    Shi, Yujiao
    Liu, Jiangang
    Liu, Chunqiu
    Shuang, Xiong
    Yang, Chenguang
    Qiao, Wenbo
    Dong, Guoju
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [49] Genetic Regulation Of Soluble Suppression Of Tumorigenicity-2 Expression In Acute Respiratory Distress Syndrome
    Chen, C. -Y.
    Barnett, I.
    Bajwa, E.
    Wei, Y.
    Wang, Z.
    Sul, L.
    Christiani, D. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [50] Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis
    Zhang, Ying
    Fan, Zixu
    Liu, Hua
    Ma, Jianwei
    Zhang, Min
    CORONARY ARTERY DISEASE, 2020, 31 (07) : 628 - 635
12345